Trump’s Proposed Budget Would Cut Science Funding

The NIH could see its budget slashed by $5.8 billion (approximately 19 percent), while the EPA could see a $2.6 billion budget cut (around 31 percent).

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIAAs anticipated, the Trump administration’s budget proposal includes substantial cuts at federal research agencies, including the US National Institutes of Health (NIH) and the Environmental Protection Agency (EPA). If approved by Congress, the budget would enact cuts of $5.8 billion at the NIH—nearly 19 percent of the agency’s current budget—and more than $2.6 billion at the EPA—around 31 percent of the agency’s current allotment.

“A $6 billion cut to the National Institutes of Health is unacceptable to the scientific community, and should be unacceptable to the American public as well,” Benjamin Corb, director of public affairs at the American Society for Biochemistry and Molecular Biology, said in a statement. “President Donald Trump’s fiscal year 2018 spending plan erases years’ worth of bipartisan support for the NIH, and the American biomedical research enterprise, which has long been the global leader for biomedical innovation. Cuts this deep threaten America’s ability to [remain] a leader.”

The US Department of Health and Human Services (HHS)—which includes the NIH, the Centers for Disease Control and Prevention (CDC), and other agencies—would see an approximate 18 percent budget cut overall. While the administration’s budget proposal does ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies